| Bristol-Myers Squibb SA - Inrebic 100 mg, Hartkapseln | | 67792 | | 01 | | Inrebic 100 mg | | Hartkapseln | | L01EJ02 | | Fedratinib | | 01.07.2021 | | |
| | Composition | | fedratinibum 100 mg ut fedratinibi dihydrochloridum monohydricum, cellulosum microcristallinum silicificatum, natrii stearylis fumaras corresp. natrium 0.18 mg, Kapselhülle: gelatina, E 172 (rubrum), E 171, Drucktinte: lacca, E 171, propylenglycolum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Fedratinibum | 100 mg |
| | BAG: Active Agent | Dose |
|---|
| Fedratinibum | 100 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Natrii Stearylis Fumaras | | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
